Effect of TP-452 in dyslipidemia

Trial Profile

Effect of TP-452 in dyslipidemia

Phase of Trial: Phase I

Latest Information Update: 29 Jan 2016

At a glance

  • Drugs TP 452 (Primary)
  • Indications Dyslipidaemias
  • Focus Adverse reactions
  • Sponsors Thetis Pharmaceuticals
  • Most Recent Events

    • 29 Jan 2016 New trial record
    • 27 Jan 2016 According to Thetis Pharmaceuticals media release, company is planning to initiate this study in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top